| The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ... Leukemia 36 (7), 1720-1748, 2022 | 2633 | 2022 |
| MYC translocation‐negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation E Leucci, M Cocco, A Onnis, G De Falco, P Van Cleef, C Bellan, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2008 | 268 | 2008 |
| Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas C Bellan, S Lazzi, M Hummel, N Palummo, M de Santi, T Amato, J Nyagol, ... Blood 106 (3), 1031-1036, 2005 | 206 | 2005 |
| Distinct viral and mutational spectrum of endemic Burkitt lymphoma F Abate, MR Ambrosio, L Mundo, MA Laginestra, F Fuligni, M Rossi, ... PLoS pathogens 11 (10), e1005158, 2015 | 179 | 2015 |
| Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes PP Piccaluga, G De Falco, M Kustagi, A Gazzola, C Agostinelli, C Tripodo, ... Blood, The Journal of the American Society of Hematology 117 (13), 3596-3608, 2011 | 154 | 2011 |
| The RET/PTC Oncogene Is Frequently Activated in Oncocytic Thyroid Tumors (Hurthle Cell Adenomas and Carcinomas), but Not in Oncocytic Hyperplastic Lesions G Chiappetta, P Toti, F Cetta, A Giuliano, F Pentimalli, I Amendola, ... The Journal of Clinical Endocrinology & Metabolism 87 (1), 364-369, 2002 | 133 | 2002 |
| Burkitt’s lymphoma: new insights into molecular pathogenesis C Bellan, S Lazzi, G De Falco, A Nyongo, A Giordano, L Leoncini Journal of clinical pathology 56 (3), 188-192, 2003 | 130 | 2003 |
| Lymphomas in sub‐Saharan Africa–what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? KN Naresh, M Raphael, L Ayers, N Hurwitz, V Calbi, E Rogena, S Sayed, ... British journal of haematology 154 (6), 696-703, 2011 | 120 | 2011 |
| Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes C Cinti, L Leoncini, A Nyongo, F Ferrari, S Lazzi, C Bellan, R Vatti, ... The American journal of pathology 156 (3), 751-760, 2000 | 108 | 2000 |
| Class 1, 2, and 3 BRAF-Mutated Metastatic Colorectal Cancer: A Detailed Clinical, Pathologic, and Molecular Characterization M Schirripa, P Biason, S Lonardi, N Pella, MS Pino, F Urbano, C Antoniotti, ... Clinical Cancer Research 25 (13), 3954-3961, 2019 | 99 | 2019 |
| CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation C Bellan, G De Falco, S Lazzi, P Micheli, S Vicidomini, K Schürfeld, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004 | 98 | 2004 |
| B‐cell differentiation in EBV‐positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA‐altered expression E Leucci, A Onnis, M Cocco, G De Falco, F Imperatore, A Giuseppina, ... International journal of cancer 126 (6), 1316-1326, 2010 | 97 | 2010 |
| The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilin MR Ambrosio, PP Piccaluga, M Ponzoni, BJ Rocca, V Malagnino, ... Public Library of Science 7 (8), e44315, 2012 | 90 | 2012 |
| The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphoma MR Ambrosio, M Navari, L Di Lisio, EA Leon, A Onnis, S Gazaneo, ... Infectious agents and cancer 9, 1-12, 2014 | 89 | 2014 |
| The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis J Nyagol, E Leucci, A Omnis, G De Falco, C Tigli, F Sanseverino, ... Cancer biology & therapy 5 (6), 684-690, 2006 | 83 | 2006 |
| Diagnosis of Burkitt lymphoma using an algorithmic approach–applicable in both resource‐poor and resource‐rich countries KN Naresh, HAH Ibrahim, S Lazzi, P Rince, M Onorati, MR Ambrosio, ... British journal of haematology 154 (6), 770-776, 2011 | 74 | 2011 |
| Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis S Lazzi, C Bellan, G De Falco, C Cinti, F Ferrari, A Nyongo, PP Claudio, ... Human pathology 33 (7), 723-731, 2002 | 74 | 2002 |
| HIV-associated malignant lymphomas in Kenya (Equatorial Africa) S Lazzi, F Ferrari, A Nyongo, N Palummo, A De Milito, M Zazzi, L Leoncini, ... Human pathology 29 (11), 1285-1289, 1998 | 72 | 1998 |
| Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas L Mundo, L Del Porro, M Granai, MC Siciliano, V Mancini, R Santi, ... Modern Pathology 33 (12), 2407-2421, 2020 | 68 | 2020 |
| Interaction between HIV-1 Tat and pRb2/p130: a possible mechanism in the pathogenesis of AIDS-related neoplasms G De Falco, C Bellan, S Lazzi, PP Claudio, D La Sala, C Cinti, P Tosi, ... Oncogene 22 (40), 6214-6219, 2003 | 68 | 2003 |
